Lockheed Martin’s roughly $124 billion market capitalization and Anduril’s secondary-market indications near or above $100–112 billion underpin the near-even 51% market-implied odds that Lockheed will hold the higher valuation at year-end. Traders weigh Lockheed’s stable cash flows, $77 billion trailing revenue, and single-digit growth against Anduril’s rapid revenue doubling to $2.2 billion in 2025, repeated valuation doublings in primary rounds, and expanding contract pipeline, while discounting private-valuation volatility and potential dilution. Lockheed’s third-quarter results on October 20 and any Anduril follow-on funding or IPO signals before December 31 represent the clearest near-term catalysts that could shift the balance.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于Anduril
51% 概率
最新
最新
2027-01-01
Anduril
51% 概率
最新
最新
2027-01-01
This market will resolve to the listed company with the larger valuation, as measured by the final NPM Price reported by Nasdaq Private Market, LLC (NPM) and the official closing price for the public company, for December 31, 2026.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://test8298192.pages.dev/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Lockheed Martin’s roughly $124 billion market capitalization and Anduril’s secondary-market indications near or above $100–112 billion underpin the near-even 51% market-implied odds that Lockheed will hold the higher valuation at year-end. Traders weigh Lockheed’s stable cash flows, $77 billion trailing revenue, and single-digit growth against Anduril’s rapid revenue doubling to $2.2 billion in 2025, repeated valuation doublings in primary rounds, and expanding contract pipeline, while discounting private-valuation volatility and potential dilution. Lockheed’s third-quarter results on October 20 and any Anduril follow-on funding or IPO signals before December 31 represent the clearest near-term catalysts that could shift the balance.
This market will resolve to the listed company with the larger valuation, as measured by the final NPM Price reported by Nasdaq Private Market, LLC (NPM) and the official closing price for the public company, for December 31, 2026.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://test8298192.pages.dev/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://test8298192.pages.dev/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
市场开放时间： May 19, 2026, 4:25 PM ET
交易量
$9,267结束日期
2027-01-01市场开放时间
May 19, 2026, 4:25 PM ETThis market will resolve to the listed company with the larger valuation, as measured by the final NPM Price reported by Nasdaq Private Market, LLC (NPM) and the official closing price for the public company, for December 31, 2026.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://test8298192.pages.dev/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.Lockheed Martin’s roughly $124 billion market capitalization and Anduril’s secondary-market indications near or above $100–112 billion underpin the near-even 51% market-implied odds that Lockheed will hold the higher valuation at year-end. Traders weigh Lockheed’s stable cash flows, $77 billion trailing revenue, and single-digit growth against Anduril’s rapid revenue doubling to $2.2 billion in 2025, repeated valuation doublings in primary rounds, and expanding contract pipeline, while discounting private-valuation volatility and potential dilution. Lockheed’s third-quarter results on October 20 and any Anduril follow-on funding or IPO signals before December 31 represent the clearest near-term catalysts that could shift the balance.
This market will resolve to the listed company with the larger valuation, as measured by the final NPM Price reported by Nasdaq Private Market, LLC (NPM) and the official closing price for the public company, for December 31, 2026.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://test8298192.pages.dev/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
NPM Prices are published for trading days only and are updated once daily at 1:00 PM ET on the following calendar day.
If NPM has not published relevant data for the specified date by 1:00 PM ET on January 1, 2027, this market may remain open until 11:59 PM ET on January 4, 2027. If no further data is released by that time, the market will resolve according to the latest data available.
If NPM ceases publishing relevant data prior to the specified date, this market will resolve based on the NPM data published prior to the cessation of coverage, as well as applicable public market capitalization data following an IPO or direct listing.
If the private company completes an IPO or direct listing before the specified date, this market will resolve according to the company's public market capitalization at the market close of the specified date or the most recent trading day.
Public market capitalization will be determined using the final official regular-hours trading price published for the company's primary listed common equity on its primary exchange for the specified date or the most recent trading day, multiplied by the company's total outstanding common shares at the relevant time.
If a listed company merges with or acquires another entity and remains the parent company, no change to resolution methodology applies.
If a listed company is acquired, merges into another entity and is no longer the surviving parent company, or otherwise ceases to exist as an independent entity prior to the end of the period, only the NPM valuation and applicable public market capitalization achieved prior to completion of the transaction will be considered for resolution. No transaction, acquisition, or merger consideration will be considered for resolution.
The resolution source for the private company is NPM data published here (https://fe.secondmarket.com/companies/company-c62b8140-fdeb-428d-a9a6-d04eb3b24b49/data?return_url=https://test8298192.pages.dev/finance/privates). The resolution source for any period following an IPO, direct listing, or relevant corporate action, will be official exchange trading data and publicly reported share counts.
If Anduril's valuation is equal to Lockheed Martin's public market capitalization at resolution, this market will resolve to 50-50.
Revisions to previously published NPM data made after their initial release will not be considered, unless made to correct clearly erroneous data.
交易量
$9,267结束日期
2027-01-01市场开放时间
May 19, 2026, 4:25 PM ETLockheed Martin’s roughly $124 billion market capitalization and Anduril’s secondary-market indications near or above $100–112 billion underpin the near-even 51% market-implied odds that Lockheed will hold the higher valuation at year-end. Traders weigh Lockheed’s stable cash flows, $77 billion trailing revenue, and single-digit growth against Anduril’s rapid revenue doubling to $2.2 billion in 2025, repeated valuation doublings in primary rounds, and expanding contract pipeline, while discounting private-valuation volatility and potential dilution. Lockheed’s third-quarter results on October 20 and any Anduril follow-on funding or IPO signals before December 31 represent the clearest near-term catalysts that could shift the balance.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题